HUMAN PAPILLOMAVIRUS-18 POSITIVE

Clinical trials for HUMAN PAPILLOMAVIRUS-18 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HUMAN PAPILLOMAVIRUS-18 POSITIVE trials appear

Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-18 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

DNA vaccine shows promise against anal precancer in HIV patients

Disease control Completed

This study tested a DNA-based vaccine called VGX-3100 in 44 HIV-positive adults with high-grade anal precancer caused by HPV types 16 or 18. The vaccine was given with a mild electrical pulse (electroporation) to help cells absorb it and boost the immune response. The goal was to…

Matched conditions: HUMAN PAPILLOMAVIRUS-18 POSITIVE

Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

HUMAN PAPILLOMAVIRUS-18 POSITIVE

Get alerted when new HUMAN PAPILLOMAVIRUS-18 POSITIVE trials appear

DNA vaccine shows promise against anal precancer in HIV patients